Contact this trialFirst, we need to learn more about you.
Radiation
SG + Radiation Therapy for Bladder Cancer
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial explores the safety and tolerability of a drug (SG) combined with radiation therapy to help treat localized bladder cancer. Patients receive SG for 3 cycles during 8 weeks of treatment, then monitored for up to 5 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.